XCOPRI
Total Payments
$17.6M
Transactions
16,960
Doctors
4,598
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $3.8M | 2,894 | 1,272 |
| 2023 | $4.5M | 4,893 | 1,514 |
| 2022 | $4.6M | 4,512 | 1,706 |
| 2021 | $4.1M | 4,413 | 1,672 |
| 2020 | $578,519 | 248 | 48 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $7.3M | 1,108 | 41.5% |
| Honoraria | $6.6M | 2,712 | 37.7% |
| Consulting Fee | $2.2M | 293 | 12.5% |
| Travel and Lodging | $715,125 | 2,429 | 4.1% |
| Food and Beverage | $641,342 | 8,388 | 3.6% |
| Education | $90,584 | 2,025 | 0.5% |
| Grant | $18,000 | 4 | 0.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $525.00 | 1 | 0.0% |
Payments by Type
General
$10.3M
15,852 transactions
Research
$7.3M
1,108 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| YKP3089C045 | SK Life Science, Inc. | $1.7M | 0 |
| YKP3089C040 | SK Life Science, Inc. | $1.5M | 0 |
| 059566 | SK Life Science, Inc. | $933,230 | 0 |
| YKP3089C039 | SK Life Science, Inc. | $893,244 | 0 |
| YKP3089C025 | SK Life Science, Inc. | $670,322 | 0 |
| YKP3089C033 | SK Life Science, Inc. | $386,713 | 0 |
| YKP3089C013 | SK Life Science, Inc. | $301,418 | 0 |
| 1-Q3RAS | SK Life Science, Inc. | $256,345 | 0 |
| YKP3089C021 | SK Life Science, Inc. | $234,695 | 0 |
| 045569 | SK Life Science, Inc. | $153,487 | 0 |
| 1-FA7759 | SK Life Science, Inc. | $144,248 | 0 |
| YKP3089C049 | SK Life Science, Inc. | $72,950 | 0 |
| Dr. Rosenfeld CNS consulting | SK Life Science, Inc. | $30,135 | 1 |
Top Doctors Receiving Payments for XCOPRI
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Los Angeles, CA | $7.3M | 1,140 |
| , M.D | Neurology | Saint Louis, MO | $2.0M | 385 |
| , MD | Neurology | Cleveland, OH | $415,035 | 362 |
| , M.D | Neurology | Tulsa, OK | $370,034 | 428 |
| , MD | Neurology | Tampa, FL | $300,948 | 374 |
| , M.D | Neurology | San Francisco, CA | $273,853 | 236 |
| , MD | Neurology | Chicago, IL | $254,043 | 205 |
| , MD | Epilepsy | Washington, DC | $251,965 | 210 |
| , MD | Neurology | Bethesda, MD | $221,543 | 181 |
| , MD | Neurology | Nashville, TN | $187,151 | 204 |
| , M.D | Specialist | Brooklyn, NY | $183,051 | 173 |
| , MD | Epilepsy | Grand Rapids, MI | $134,087 | 107 |
| , MD, PHD, FAAN | Clinical Neurophysiology | Boise, ID | $132,977 | 106 |
| , M.D | Neurology | Rockford, IL | $123,400 | 180 |
| , M.D | Neurology | Phoenix, AZ | $119,785 | 137 |
| , M.D | Neurology | Cincinnati, OH | $113,240 | 118 |
| , M.D | Neurology | Atlanta, GA | $112,892 | 93 |
| , MD | Epilepsy | Cincinnati, OH | $106,404 | 92 |
| , M.D | Clinical Neurophysiology | Saint Petersburg, FL | $106,065 | 105 |
| , MD | Neurology | Houston, TX | $105,234 | 110 |
| , M.D | Neurodevelopmental Disabilities | Los Angeles, CA | $101,122 | 106 |
| , M.D | Neurology | Mobile, AL | $100,079 | 83 |
| , M.D | Internal Medicine | Chicago, IL | $97,520 | 101 |
| , MD | Clinical Neurophysiology | Los Angeles, CA | $97,347 | 99 |
| , MD | Epilepsy | New Orleans, LA | $96,077 | 81 |
Ad
Manufacturing Companies
- SK Life Science, Inc. $17.6M
Product Information
- Type Drug
- Total Payments $17.6M
- Total Doctors 4,598
- Transactions 16,960
About XCOPRI
XCOPRI is a drug associated with $17.6M in payments to 4,598 healthcare providers, recorded across 16,960 transactions in the CMS Open Payments database. The primary manufacturer is SK Life Science, Inc..
Payment data is available from 2020 to 2024. In 2024, $3.8M was paid across 2,894 transactions to 1,272 doctors.
The most common payment nature for XCOPRI is "Unspecified" ($7.3M, 41.5% of total).
XCOPRI is associated with 13 research studies, including "YKP3089C045" ($1.7M).